We are open as normal during COVID-19 pandemic. Order online, same day shipping out from North Carolina, USA
WARNING: This product is for research use only, not for human or veterinary use.
AFG206 is the novel first-generation "type II" FLT3 inhibitor.
Price and Availability
Pricing updated 2020-10-24.
Prices are subject to change without notice.
AFG206, purity > 98%, is not in stock, may be available through custom synthesis. For cost-effective reason, minimum 1 gram order is requested. The product will be characterized by NMR, HPLC and MS analysis. Purity (HPLC) is usually >98%. CoA, QC data, MSDS will be provided when product is successfully made. The estimated lead time is 2-3 months. Please send email to email@example.com to inquire quote.
MedKoo Cat#: 406214
Chemical Formula: C20H19N3O2
Exact Mass: 333.14773
Molecular Weight: 333.38
Elemental Analysis: C, 72.05; H, 5.74; N, 12.60; O, 9.60
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Soluble in DMSO, not in water
>5 years if stored properly
This drug may be formulated in DMSO
Stock Solution Storage:
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code:
1: Ellen Weisberg, Johannes Roesel, Pascal Furet, Guido Bold, Patricia Imbach, Andreas FlÃ¶rsheimer, Georgio Caravatti, Jingrui Jiang, Paul Manley, Arghya Ray, James D. Griffin. Antileukemic Effects of Novel First- and Second-Generation FLT3 Inhibitors: Structure-Affinity Comparison. Genes Cancer. 2010 October; 1(10): 1021Â–1032. doi: 10.1177/1947601910396505 PMCID: PMC3092267